The aim of this study was to compare the two modalities, mpMRI and PSMA-PET/CT, in terms of sensitivity and specificity, for the intraprostatic detection of prostate cancer lesions prior to focal HDR brachytherapy. The gene discussed is FOLH1; the disease is Familial prostate cancer.